Evidence map›Paper›PMID 39150268›Full record

ArticleInfection and immunity2024

RSV enhances

Helen E Rich, Simran Bhutia, Francina Gonzales de Los Santos, Gabrielle P Entrup, Helen I Warheit-Niemi, Stephen J Gurczynski, Monica Bame, Michael T Douglas, Susan B Morris, Rachel L Zemans and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Helen E RichDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Simran BhutiaDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Francina Gonzales de Los SantosDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Gabrielle P EntrupDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Helen I Warheit-NiemiDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Stephen J GurczynskiDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Monica BameDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Michael T DouglasDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Susan B MorrisDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Rachel L ZemansDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Nicholas W LukacsDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Bethany B MooreDepartment of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0003-3051-745X

Funding

RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
Immunobiology of Lung Injury and FibrosisR35HL144481 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2019 to 2024
$5.2M
Viral and allergen-driven immunity in chronic lung diseaseR35HL150682 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Nicholas W Lukacs · 2020 to 2026
$4.8M
Mechanisms of Alveolar Homeostasis, Injury, Regeneration, and FibrosisR35HL160770 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Rachel Lynne Zemans · 2022 to 2026
$4.3M
Dissecting the Role of DDR2 in the Modulation of Antibacterial Host Defense Post Fibrotic Lung InjuryF31HL152509 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WARHEIT-NIEMI, HELEN IVORY · 2020 to 2022
$88k
HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R35HL144481HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R35HL150682HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) T32AI007413HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) F31DK163865NHLBI NIH HHS R35 HL144481NHLBI NIH HHS R35 HL150682NHLBI NIH HHS R35 HL160770NHLBI NIH HHS R35HL160770NIAID NIH HHS T32 AI007413University of Michigan Postdoctoral Pioneer Program
6 · The paper itself

Abstract

Patients coinfected with respiratory syncytial virus (RSV) and bacteria have longer hospital stays, higher risk of intensive care unit admission, and worse outcomes. We describe a model of RSV line 19F/methicillin-resistant

Indexed as

CoinfectionLungMacrophages, AlveolarMethicillin-Resistant Staphylococcus aureusNeutrophilsRespiratory Syncytial Virus InfectionsStaphylococcal InfectionsAnimalsDisease Models, AnimalExtracellular TrapsFemaleHumansMicePhagocytosisReactive Oxygen SpeciesRespiratory Syncytial VirusesReactive Oxygen Speciesalveolar macrophagelungMRSAneutrophilrespiratory syncitial virus

Identifiers

PMID39150268
PMCPMC11475690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.